Cherie Blair firm's FSA authorisation claim vanishes

clock

The Allele Fund, a company co-founded by Cherie Blair, has removed a claim on its website that it is authorised by the Financial Services Authority (FSA).

The FSA today told the Telegraph it has no knowledge or record of the Allele Fund, which invests in healthcare and technology companies. A spokesperson for the fund told the paper that its website does not claim to be authorised. In its current form, the site makes no such claim. However, a cached version of the website dated 29 December 2011 states: "In the United Kingdom this website is issued by Allele Fund, which is authoriSed and regulated by the FSA." A spokesman for the Allele Fund said: "FSA registration is not required for the Allele Fund, as under the FSA definition there...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Regulation

FOS reveals next phase of reforms

FOS reveals next phase of reforms

Including new powers to dismiss certain cases

Isabel Baxter
clock 11 August 2026 • 3 min read
Court sets trial date in illegal financial promotions case

Court sets trial date in illegal financial promotions case

Lucy Beck pleads not guilty

Sophia Panayi
clock 31 July 2026 • 1 min read
FCA flags weak customer outcome focus in firms' monitoring frameworks

FCA flags weak customer outcome focus in firms' monitoring frameworks

Consumer Duty review found inconsistent governance and oversight

Sophia Panayi
clock 27 July 2026 • 2 min read